首页> 外文期刊>Global Pediatric Health >Impact of Age, Gender, and Addition of Probiotics on Treatment Success for Helicobacter pylori in Children:
【24h】

Impact of Age, Gender, and Addition of Probiotics on Treatment Success for Helicobacter pylori in Children:

机译:年龄,性别和益生菌添加对儿童幽门螺杆菌治疗成功的影响:

获取原文
       

摘要

The primary objective of this study was to evaluate the effect of age, gender, and the use of probiotics with standard treatment regimen on Helicobacter pylori eradication. Based on endoscopic findings and clinical presentation, selected patients were treated with standard triple therapy (omeprazole, clarithromycin, and amoxicillin). Those who failed were offered a repeat treatment with omeprazole, metronidazole, and amoxicillin. After the publications of the possible advantages of probiotic treatment on H pylori eradication, the probiotic agent “Probiotica Forte” was routinely added to the treatment. Eradication was noted for 94/130 patients (72%) and for 128/197 patients (65%) with or without probiotic agent, respectively (P = .23). For second-line treatment eradication was noted in 33/46 (72%) and in 9/20 (45%) with or without probiotic agent, respectively (P = .053). The addition of probiotics may improve eradication success especially in addition to second-line treatment.
机译:这项研究的主要目的是评估年龄,性别以及标准治疗方案下益生菌的使用对根除幽门螺杆菌的影响。根据内窥镜检查结果和临床表现,选择的患者接受了标准的三联疗法(奥美拉唑,克拉霉素和阿莫西林)治疗。失败者将再次接受奥美拉唑,甲硝唑和阿莫西林治疗。在发表了益生菌治疗对幽门螺杆菌根除的可能优势的出版物之后,常规将益生菌制剂“ Probiotica Forte”添加到治疗中。分别发现有或没有益生菌药物的患者分别为94/130(72%)和128/197(65%)(P = .23)。对于二线治疗,在有或没有益生菌的情况下,根除率分别为33/46(72%)和9/20(45%)(P = .053)。益生菌的添加特别是除了二线治疗以外,还可以改善根除成功率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号